Merck & Co. Inc. buy UBS Group AG
Start price
31.07.24
/
50%
€104.60
Target price
31.07.25
€131.36
Performance (%)
-34.80%
End price
01.08.25
€68.20
Summary
This prediction ended on 01.08.25 with a price of €68.20. The BUY prediction by UBS_Group_AG for Merck & Co. Inc. performed very badly with a performance of -34.80%. UBS_Group_AG has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.27 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 5.304% | 5.304% | -1.550% |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at UBS Group AG from $148.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Merck & Co. Inc.
Stopped prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€117.60
02.02.24
02.02.24
€137.06
02.02.25
02.02.25
-18.88%
03.02.25
03.02.25
